Sun.May 07, 2023

article thumbnail

Happy National Nurses Week!

OctariusRx

Happy National Nurses Week to all our nursing colleagues, clients, friends, and family. National Nurses Week is from Saturday May 6 th through May 12th, Florence Nightingale ’s birthday. As usual, the OctariusRx team is taking time to recognize and celebrate all the contributions and sacrifices nurses make daily. Cheers to all nurses! Because you consistently put the well-being of others before your own, you are our heroes.

78
article thumbnail

How to Ease Leg Cramps with Mustard

The People's Pharmacy

When a leg cramp strikes in the middle of the night, it results in a rude awakening. Sometimes the pain can bring tears to a person’s eyes. Finding relief is just as urgent if you are in the middle of an important activity, such as running, biking or scuba diving. Consequently, a way to ease leg cramps quickly and effectively is most welcome! Scuba Diver Uses Mustard to Ease Leg Cramps: Q.

72
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Rise and Recognition

PharmExec

This year marks my first involvement in Pharmaceutical Executive’s Emerging Pharma Leaders (EPL) Awards, and what a ride it has been. We received so many wonderful nominations, and it’s always humbling to learn about some of the intricacies of the research that’s being done as well as the accomplishments of both current leaders and up-and-coming leaders.

52
article thumbnail

Pharma á la carte – 5/9/23

The Honest Apothecary

Here I share some of the latest news, articles, editorials, or blog posts that fall generally under the theme of Pharma or healthcare. I might throw in a something off-topic from time to time which I found while wandering throughout the endless hallways and corridors of the internet. All article shared will be free to read and not locked behind an annoying paywall.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Pharmaceutical Executive, May 2023 Issue (PDF)

PharmExec

Click the title above for a link to open the Pharmaceutical Executive April 2023 issue in an interactive PDF format.

52
article thumbnail

Formosa, AimMax submit NDA to FDA for new pain therapy

Pharmaceutical Technology

Formosa Pharmaceuticals along with AimMax Therapeutics has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for APP13007, a new formulation to treat inflammation and pain after ocular surgery. APP13007 is an aqueous nanosuspension formulation of the potent corticosteroid, clobetasol propionate (0.05%). The homogeneous nanosuspension looks like a solution that provides improved comfort to the eyes and helps drug penetrate well into ocular tissues.

FDA 52

More Trending

article thumbnail

As FREE As Amazon Will Let Me! MPJE Federal Law Book – Offer Will End Soon!

Med Ed 101

I enjoy giving back to those who follow the blog closely and I hope this will help a lot of students and pharmacists with their MPJE preparations! I’m pricing the 2nd Edition (Bigger and Better than the first edition!) of MPJE Master as cheap as Amazon will let me. Spoiler alert – It is $0.99! […] The post As FREE As Amazon Will Let Me!

52
article thumbnail

Bliss Biopharmaceutical Entered into a Clinical Trial Collaboration Agreement with Eisai for BB-1701 to Treat Cancers

PharmaShots

Shots: BlissBio will receive up front & milestones. If Eisai exercises its option, BlissBio will also receive an option exercise fee, ~$2B in development & commercial milestones along with royalties. Both companies will conduct co-development activities related to BB-1701 through an option period Upon the option exercise, Eisai to get a right globally (excl.

40